Agios Pharmaceuticals, Inc.

AGIONASDAQHealthcare● Active

$27.90

$-0.40(-1.40%)

Market Cap$1.7B

P/E Ratio—

52W High$46

52W Low$22.24

Avg Volume1.0M

Open$28.66

Beta0.59

Overview

Agios Pharmaceuticals, Inc. (AGIO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · AGIO · as of Feb 12, 2026

Latest filing snapshot

539

+53+10.91%vs prior year

Agios Pharmaceuticals, Inc. (AGIO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

539

Change (1Y)

+53

Growth % (1Y)

+10.91%

Revenue / Employee

$100.2K

Net Income / Employee

$-765.8K

Market Cap

$1.7B

AGIO Employee Count

2013 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-12	2025-12-31	539	+53	+10.91%
2025-02-13	2024-12-31	486	+103	+26.89%
2024-02-15	2023-12-31	383	-6	-1.54%
2023-02-23	2022-12-31	389	-1	-0.26%
2022-02-24	2021-12-31	390	-172	-30.60%
2021-02-25	2020-12-31	562	+26	+4.85%
2020-02-19	2019-12-31	536	+54	+11.20%
2019-02-14	2018-12-31	482	+100	+26.18%
2018-02-14	2017-12-31	382	+95	+33.10%
2017-02-16	2016-12-31	287	+79	+37.98%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Agios Pharmaceuticals, Inc.YOU

539$1.7B #4

DNLI

Denali Therapeutics Inc.

443$3.1B #5

BEAM

Beam Therapeutics Inc.

393$3.1B #6

COGT

Cogent Biosciences, Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · AGIO peer comparison

About AGIO employees

AGIO Employees · Headcount

Agios Pharmaceuticals, Inc. (AGIO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Agios Pharmaceuticals, Inc. had 539 full-time employees globally. Full-time employees only. Global consolidated headcount.

Agios Pharmaceuticals, Inc. employs 539 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $100,237, reflecting the company's operational efficiency.

Agios Pharmaceuticals, Inc.'s workforce increased by 53 (10.91%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Agios Pharmaceuticals, Inc.'s revenue per employee of $100,237 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

AGIO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Agios Pharmaceuticals, Inc. had 539 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Agios Pharmaceuticals, Inc. employee counthow many employees does Agios Pharmaceuticals, Inc. haveAGIO total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-12